Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Che

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Journal of Gastroenterology and Hepatology|February 7, 2024
Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resectionWenhui Zhong, Bowen Xu, Yiming Lu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|February 6, 2007
[Clinical significance of solitary lymph node metastasis in carcinoma of the ampulla of Vater]Yi Shan, Dong-bing Zhao, Xu Che, et al.
Clinical Laboratory|February 18, 2016
Association of Genetic Polymorphisms in UDP-Glucuronosyltransferases 2B17 with the Risk of Pancreatic Cancer in Chinese Han PopulationXu Che, Dianke Yu, Zongyong Wu, et al.
International Journal of Clinical and Experimental Medicine|May 2, 2015
Polymorphisms in UGT2B4 and susceptibility to pancreatic cancerXu Che, Dianke Yu, Zongyong Wu, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Gamma-Glutamyl Transferase Plus Carcinoembryonic Antigen Ratio Index: A Promising Biomarker Associated with Treatment Response to Neoadjuvant Chemotherapy for Patients with Colorectal Cancer Liver MetastasesYanjiang Yin, Bowen Xu, Jianping Chang, et al.
Scientific Reports|August 9, 2025
Efficacy and safety of anlotinib monotherapy for advanced hepatocellular carcinoma and clinical role of α-fetoproteinJianping Chang, Bowen Xu, Zhiyu Li, et al.
Frontiers in Immunology|June 5, 2025
The impact of immune checkpoint inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a meta-analysisWei Zhang, Zirong Liu, Hongjin Liu, et al.
Cancer Cell International|April 6, 2024
MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1Zhicheng Wei, Bowen Xu, Yanjiang Yin, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|May 25, 2006
[Recurrence patterns and surgical treatment for recurrent colon cancer after radical resection]Yi Shan, Xu Che, Dong-bing Zhao, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|March 24, 2007
[Surgical management of ovarian metastasis from colorectal cancer]Yi Shan, Xu Che, Dong-bing Zhao, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Journal of Gastroenterology and Hepatology|February 7, 2024
Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resectionWenhui Zhong, Bowen Xu, Yiming Lu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|February 6, 2007
[Clinical significance of solitary lymph node metastasis in carcinoma of the ampulla of Vater]Yi Shan, Dong-bing Zhao, Xu Che, et al.
Clinical Laboratory|February 18, 2016
Association of Genetic Polymorphisms in UDP-Glucuronosyltransferases 2B17 with the Risk of Pancreatic Cancer in Chinese Han PopulationXu Che, Dianke Yu, Zongyong Wu, et al.
International Journal of Clinical and Experimental Medicine|May 2, 2015
Polymorphisms in UGT2B4 and susceptibility to pancreatic cancerXu Che, Dianke Yu, Zongyong Wu, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Gamma-Glutamyl Transferase Plus Carcinoembryonic Antigen Ratio Index: A Promising Biomarker Associated with Treatment Response to Neoadjuvant Chemotherapy for Patients with Colorectal Cancer Liver MetastasesYanjiang Yin, Bowen Xu, Jianping Chang, et al.
Scientific Reports|August 9, 2025
Efficacy and safety of anlotinib monotherapy for advanced hepatocellular carcinoma and clinical role of α-fetoproteinJianping Chang, Bowen Xu, Zhiyu Li, et al.
Frontiers in Immunology|June 5, 2025
The impact of immune checkpoint inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a meta-analysisWei Zhang, Zirong Liu, Hongjin Liu, et al.
Cancer Cell International|April 6, 2024
MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1Zhicheng Wei, Bowen Xu, Yanjiang Yin, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|May 25, 2006
[Recurrence patterns and surgical treatment for recurrent colon cancer after radical resection]Yi Shan, Xu Che, Dong-bing Zhao, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|March 24, 2007
[Surgical management of ovarian metastasis from colorectal cancer]Yi Shan, Xu Che, Dong-bing Zhao, et al.
Pageof 12